CD6 and viral infectious disease: CD6 inhibited the drug-resistant virus at very low concentrations (IC50: 28±10 ng ml−1; Supplementary Fig. 7), highlighting the potential of the CD6 epitope to serve as a target for alternative antibody therapeutics against pH1N1 virus infection.